Synthecon, Inc. is a biotechnology company based in Houston, Texas, specializing in advanced cell culture technologies. The company focuses on developing innovative solutions for 3D cell culture, which enhances the efficiency and effectiveness of drug discovery and tissue engineering. By leveraging its proprietary bioreactor systems, Synthecon aims to improve the physiological relevance of in vitro models, facilitating breakthroughs in regenerative medicine and therapeutic development. Its commitment to research and development positions it at the forefront of biotechnological advancements.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

13 Patents

#390 in Houston, TX

#1,488 in Texas

#23,854 in US

#45,081 in the World

Houston, TX, United States of America

Synthecon, Inc.

Forward Citations = 383

9 inventors:

Stephen S Navran, Jr (7 out of 7 patents)

William J Anderson (7 out of 7 patents)

Ray P Schwarz (6 out of 13 patents)

4. Roger Akers (4 out of 4 patents)

5. Adrian F Dinges, Jr (3 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Synthecon, Inc.. Retrieved from https://idiyas.com/company/synthecon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]